| RR of non-enrolled vs. School Clinic (SC) as reference | RR of non-enrolled vs. No School Clinic (NSC) as reference |
---|---|---|
Pregnancya | ||
 RR (95 % CI): Q1 | 1.7 (1.6–1.9) | 2.0 (1.9–2.1) |
 RR (95 % CI): Q2 | 2.2 (1.8–2.5) | 2.5 (2.3–2.7) |
 RR (95 % CI): Q3 | 2.3 (1.8–2.8) | 2.8 (2.5–3.1) |
 RR (95 % CI): Q4 | 1.8 (1.4–2.2) | 2.9 (2.5–3.3) |
 RR (95 % CI): Q5 | 2.1 (1.7–2.6) | 4.4 (3.7–5.3) |
STIsa | ||
Female | ||
 RR (95 % CI): Q1 | 1.0 (0.8–1.1) | 1.7 (1.5–1.9) |
 RR (95 % CI): Q2 | 1.4 (1.1–1.8) | 1.9 (1.6–2.3) |
 RR (95 % CI): Q3 | 1.3 (0.9–2.0) | 2.1 (1.7–2.7) |
 RR (95 % CI): Q4 | 1.1 (0.8–1.6) | 2.2 (1.6–3.0) |
 RR (95 % CI): Q5 | 1.0 (0.7–1.5) | 3.0 (2.1–4.4) |
Male | ||
 RR (95 % CI): Q1 | 1.3 (1.1–1.7) | 2.1 (1.8–2.4) |
 RR (95 % CI): Q2 | 1.5 (1.1–2.2) | 2.6 (2.0–3.3) |
 RR (95 % CI): Q3 | 1.6 (1.0–2.7) | 4.3 (3.0–6.0) |
 RR (95 % CI): Q4 | 2.0 (1.2–3.4) | 5.3 (3.5–8.0) |
 RR (95 % CI): Q5 | 2.4 (1.4–4.1) | 5.5 (3.5–8.8) |
Total | ||
 RR (95 % CI): Q1 | 1.1 (1.0–1.2) | 1.8 (1.6–2.0) |
 RR (95 % CI): Q2 | 1.4 (1.2–1.7) | 2.1 (1.8–2.4) |
 RR (95 % CI): Q3 | 1.5 (1.1–2.0) | 2.6 (2.2–3.2) |
 RR (95 % CI): Q4 | 1.3 (1.0–1.8) | 2.8 (2.2–3.6) |
 RR (95 % CI): Q5 | 1.3 (1.0–1.7) | 3.7 (2.8–5.0) |